Rocky Mount, N.C. – June 4, 2013 – GE Healthcare today announced that Nash General Hospital, a 280-bed acute care facility in Rocky Mount, North Carolina is one of the first hospitals in North Carolina to install GE’s DoseWatch* technology. DoseWatch is a new radiation dose-tracking and reporting solution that provides healthcare professionals with a standardized comprehensive view of dose data from Computer Tomography (CT), Interventional and X-ray procedures. The in-depth data enables providers to analyze, optimize and manage dose for their patients while they preserve diagnostic image quality.
By incorporating DoseWatch in a comprehensive radiation management program, healthcare providers can gain even greater visibility to the dosimetric data they possess – and most importantly the variation – so that the hospitals can effect change in how dose is administered. DoseWatch supplements existing dose tracking solutions and can be used with equipment from various vendors to help further reduce radiation dose in diagnostic imaging. To date, there are more than 100 installations of DoseWatch worldwide.
“The health of our patients is the first and foremost priority of our hospital staff,” said Jay Streater, director of imaging services at Nash General Hospital. “Having better visibility around our dose data by patient, protocol and device is powerful. We are now equipped with the right information to reduce variation and radiation dose without compromising image quality, a top priority at Nash General, and we are proud to offer our staff and patients the latest in technology to support these important efforts.”
CT, X-ray and other diagnostic imaging procedures provide critical insight to physicians for diagnosing a variety of conditions. Collaborating with GE Healthcare and leveraging innovative technologies such as DoseWatch, Nash General Hospital continues to lead in managing and reducing patient radiation dose while maintaining exceptional image quality in diagnostic procedures. The hospital was one of the first in North Carolina to implement DoseWatch as part of its leadership in dose management to enhance patient care and satisfaction.
“By providing better visibility to dosimetric data and analytics, healthcare providers are better equipped to deliver diagnostic procedures with the proper dose level, resulting in better patient outcomes and care,” said Mike Finnegan, US, Canada Commercial General Manager for Dose Services at GE Healthcare. “Nash General Hospital is truly a leader in their efforts to reduce radiation for patients. DoseWatch is one of the first steps towards a holistic dose management solution to better manage radiation dose levels by patient, protocol and device. We are proud to support Nash’s journey to drive radiation dose consistency and transparency across their organization.”
Increased clinical adoption of DoseWatch in the U.S. and internationally supports GE’s efforts to invest more than $800 million in low-dose technologies over 15 years, as well as the launch of the GE Blueprint for low dose, which includes a commitment to help leading U.S. hospitals further reduce average patient exposure to radiation dose in imaging procedures.
*Trademark of General Electric company
About Nash General Hospital/Nash Health Care:
Nash Health Care is a non-profit hospital authority comprised of five licensed hospitals totaling 403 beds: Nash General Hospital, Nash Day Hospital, the Bryant T. Aldridge Rehabilitation Center, Community Hospital and Coastal Plain Hospital.
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.